30 November 2009
Uncommon cutaneous lesions under immunosuppressive therapy
Keiji Sugiura, Mariko Sugiura, Tsuneo Ueki, Norihiko Goto, Akio Katayama, Akira ItoAm J Case Rep 2009; 10:218-220 :: ID: 878285
Abstract
Background: Sarcoidosis may be induced by CD4 T helper cell type-1 T-lymphocytes. Because the action process of cyclosporine inhibits IL-2 mediated T cells, cyclosporine is not sufficient to inhibit sarcoidosis.
Case Report: A 45-year-old man receiving immunosuppressive therapy developed erythema and scales on his face in 2007. Our diagnosis was sarcoidal granulomas based on immunohistopathological findings and no results of polymerase chain reaction for TB or mycobacterium analysis. We treated the patient
using steroid tablets and ointment, which, combined with a pulsed light system for telangiectasia, improved his condition.
Conclusions: This is a common cutaneous disease that occurs after renal transplantation, as has been seen in clinical findings. Although the patient’s conditions developed under immunosuppressive therapy, the treatment had to involve adequate steroids for the treatment of sarcoidosis after renal transplantation. Because cyclosporine was used, the occurrence of sarcoidal granulomas is an uncommon findings result.
Keywords: renal transplantation, Granuloma, sarcoidosis, immunosuppressive therapy, steroid
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945853
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947512
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946691
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946969
Most Viewed Current Articles
21 Jun 2024 : Case report
96,359
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,229
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,248
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,387
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030